A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

Leading UCSF physician-scientists are developing targeted treatments, earlier diagnostics, and helping to solve tuberculosis’ ...

Michigan has the only persisting bovine tuberculosis outbreak in wild deer anywhere in the U.S. — and it occasionally spills ...

New TB vaccines are needed TB is the leading killer worldwide by a single infectious agent, claiming more than 1.25 million lives in 2023 and infecting more than 10.6 million, according to the ...

A Tuberculosis (TB) outbreak in Kansas City, Kansas, has people on edge, with not much public knowledge about the disease or ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Kansas faces one of the largest TB outbreaks in US history. TB, an enduring pandemic, thrives in poverty-stricken areas and ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB vaccinations. These breakthroughs aim to enhance current vaccine efficacy and ...